Biotica operates a highly focused business model to retain flexibility in selecting the most high-value projects
Focus on core expertise
Biotica’s expertise and IP lie in three areas: genetically sequencing and modifying polyketide-producing bacteria (Molecular Biology), culturing them (Fermentation Microbiology) and then extracting the resulting polyketides and further modifying them (Natural Product Chemistry).
Selection of high-value projects
There are more than 2500 polyketides amenable to optimisation by Biotica’s technology. To select the most high value leads from this pool for internal programmes, Biotica uses three key criteria: clinical validation for the chosen target; Biotica exclusivity for the approach and blockbuster potential for the resulting polyketide therapeutic. More…
Use of expert advisors
Having identified a potential high-value programme, Biotica recruits a team of advisors to scope out the clinical and commercial opportunity. With the help of these advisors Biotica creates a target product profile which guides optimisation right from the start of a programme. More…